-+ 0.00%
-+ 0.00%
-+ 0.00%

TransMedics launches CHOPS cooling system to support ENHANCE Heart, DENOVO Lung trials

PUBT·04/23/2026 11:09:41
Listen to the news
TransMedics launches CHOPS cooling system to support ENHANCE Heart, DENOVO Lung trials
  • TransMedics unveiled Controlled Hypothermic Organ Preservation System (CHOPS), a new active-cooling organ preservation device, at ISHLT 2026 Annual Meeting.
  • CHOPS launch targets expanded product portfolio, supporting enrollment for control arms in OCS ENHANCE Heart Part B trial plus OCS DENOVO Lung trial.
  • FDA granted full IDE approval for Next-Generation OCS ENHANCE Heart trial in February 2026; OCS DENOVO Lung trial IDE cleared in January 2026.
  • Company plans to submit IDE amendment so CHOPS can serve as control device, enabling FDA-acceptable comparisons versus static cold storage.
  • No clinical results were reported; program updates are being presented at meeting, with FDA review of CHOPS control-arm approach expected to conclude in coming months.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transmedics Group Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: NE41806) on April 23, 2026, and is solely responsible for the information contained therein.